ArticleHeliyon2024

Efficacy and safety of different cycles of neoadjuvant immunotherapy in resectable non-small cell lung cancer: A systematic review and meta-analysis.

Linlin Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.